# Tootsie Roll Industries Inc: overview

TR · NYSE · CIK 98677 · [Consumer staples](/sectors/consumer-staples.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/tr.md) · [Financials](/companies/tr/financials.md) · [Filings](/companies/tr/filings.md) · [Insiders](/companies/tr/insiders.md)

Latest reported revenue: [$154.2m](/filings/0001104659-26-092633.md) for Q2 FY2026, three months to 2026-06-30, from the 10-Q filed Aug 7, 2026 (XBRL us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax, accession 0001104659-26-092633).

## Last eight quarters

| Line item | Unit | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [226](/filings/0001104659-25-108351.md) | [193 d](/filings/0001104659-26-021621.md) | [148](/filings/0001104659-26-057824.md) | [155](/filings/0001104659-26-092633.md) | [233](/filings/0001104659-25-108351.md) | [196 d](/filings/0001104659-26-021621.md) | [152](/filings/0001104659-26-057824.md) | [154](/filings/0001104659-26-092633.md) |
| Gross margin | % | [34.1%](/filings/0001104659-25-108351.md) | [39.1% d](/filings/0001104659-26-021621.md) | [35.3%](/filings/0001104659-26-057824.md) | [36.4%](/filings/0001104659-26-092633.md) | [34.1%](/filings/0001104659-25-108351.md) | [35.7% d](/filings/0001104659-26-021621.md) | [33.8%](/filings/0001104659-26-057824.md) | [34.1%](/filings/0001104659-26-092633.md) |
| Operating margin | % | [15.6%](/filings/0001104659-25-108351.md) | [20.0% d](/filings/0001104659-26-021621.md) | [15.5%](/filings/0001104659-26-057824.md) | [7.8%](/filings/0001104659-26-092633.md) | [13.9%](/filings/0001104659-25-108351.md) | [17.0% d](/filings/0001104659-26-021621.md) | [15.3%](/filings/0001104659-26-057824.md) | [(1.0%)](/filings/0001104659-26-092633.md) |
| Net margin | % | [14.5%](/filings/0001104659-25-108351.md) | [11.6% d](/filings/0001104659-26-021621.md) | [12.2%](/filings/0001104659-26-057824.md) | [11.3%](/filings/0001104659-26-092633.md) | [15.3%](/filings/0001104659-25-108351.md) | [14.7% d](/filings/0001104659-26-021621.md) | [11.7%](/filings/0001104659-26-057824.md) | [8.7%](/filings/0001104659-26-092633.md) |
| Diluted EPS | $ per share | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Free cash flow | $m | [55.8 d](/filings/0001104659-25-108351.md) | [64.7 d](/filings/0001104659-26-021621.md) | [0.8](/filings/0001104659-26-057824.md) | [(16.0) d](/filings/0001104659-26-092633.md) | [50.7 d](/filings/0001104659-25-108351.md) | [61.0 d](/filings/0001104659-26-021621.md) | [3.3](/filings/0001104659-26-057824.md) | [(34.8) d](/filings/0001104659-26-092633.md) |

- Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Gross margin (gross profit / revenue). XBRL Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Diluted EPS. XBRL not reported.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Derived values: 9-month figure less the 6-month figure; 12-month figure less the 9-month figure; 6-month figure less the 3-month figure.

## Last five fiscal years

| Line item | Unit | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [571](/filings/0001558370-24-002048.md) | [687](/filings/0001558370-25-001926.md) | [769](/filings/0001104659-26-021621.md) | [723](/filings/0001104659-26-021621.md) | [733](/filings/0001104659-26-021621.md) |
| Gross margin | % | [34.9%](/filings/0001558370-24-002048.md) | [33.9%](/filings/0001558370-25-001926.md) | [33.4%](/filings/0001104659-26-021621.md) | [35.0%](/filings/0001104659-26-021621.md) | [35.3%](/filings/0001104659-26-021621.md) |
| Operating margin | % | [11.8%](/filings/0001558370-24-002048.md) | [16.1%](/filings/0001558370-25-001926.md) | [13.2%](/filings/0001104659-26-021621.md) | [13.9%](/filings/0001104659-26-021621.md) | [13.8%](/filings/0001104659-26-021621.md) |
| Net margin | % | [11.4%](/filings/0001558370-24-002048.md) | [11.1%](/filings/0001558370-25-001926.md) | [11.9%](/filings/0001104659-26-021621.md) | [12.0%](/filings/0001104659-26-021621.md) | [13.7%](/filings/0001104659-26-021621.md) |
| Diluted EPS | $ per share | not reported | not reported | not reported | not reported | not reported |
| Free cash flow | $m | [53.9](/filings/0001558370-24-002048.md) | [48.7](/filings/0001558370-25-001926.md) | [67.8](/filings/0001104659-26-021621.md) | [121](/filings/0001104659-26-021621.md) | [96.4](/filings/0001104659-26-021621.md) |

- Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Gross margin (gross profit / revenue). XBRL Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Diluted EPS. XBRL not reported.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.

Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing.

## Insider purchases and sales

The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/tr/insiders.md)

None in coverage.

## Funds that report holding it

From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md)

| Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | --- | --- |
| [BlackRock, Inc.](/funds/2012383.md) | 2026-06-30 | $84.4m | 2,133,246 |  | Reduced −895,290 |
| [DIMENSIONAL FUND ADVISORS LP](/funds/354204.md) | 2026-06-30 | $46.2m | 1,168,746 |  | Added +16,032 |
| [VANGUARD PORTFOLIO MANAGEMENT LLC](/funds/2100121.md) | 2026-06-30 | $45.7m | 1,155,359 |  | Reduced −135,231 |
| [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $31.3m | 792,110 |  | Reduced −5,988 |
| [STATE STREET CORP](/funds/93751.md) | 2026-06-30 | $19.2m | 484,035 |  | Reduced −293,321 |
| [RENAISSANCE TECHNOLOGIES LLC](/funds/1037389.md) | 2026-06-30 | $18.7m | 471,926 |  | Added +18,134 |
| [MILLENNIUM MANAGEMENT LLC](/funds/1273087.md) | 2026-06-30 | $17.5m | 443,267 |  | Added +342,684 |
| [GEODE CAPITAL MANAGEMENT, LLC](/funds/1214717.md) | 2026-06-30 | $14.1m | 356,853 |  | Reduced −208,134 |
| [TWO SIGMA INVESTMENTS, LP](/funds/1179392.md) | 2026-06-30 | $11.7m | 297,050 |  | Added +71,262 |
| [HFR Wealth Management, LLC](/funds/1877822.md) | 2026-06-30 | $11.7m | 295,263 |  | Added +5,554 |

## Recent filings

[All 263 filings](/companies/tr/filings.md)

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-22 | 15:00 ET | [8-K](/filings/0001104659-26-118027.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-26-118027 |
| 2026-09-01 | 20:30 ET | [8-K](/filings/0001104659-26-104332.md) | 7.01 Regulation FD disclosure | 0001104659-26-104332 |
| 2026-08-07 | 19:00 ET | [10-Q](/filings/0001104659-26-092633.md) | Quarterly report, period 2026-06-30 | 0001104659-26-092633 |
| 2026-07-23 | 15:00 ET | [8-K](/filings/0001104659-26-086127.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-26-086127 |
| 2026-05-11 | 15:00 ET | [8-K](/filings/0001104659-26-058415.md) | 5.07 Shareholder vote results | 0001104659-26-058415 |
| 2026-05-08 | 19:01 ET | [10-Q](/filings/0001104659-26-057824.md) | Quarterly report, period 2026-03-31 | 0001104659-26-057824 |
| 2026-04-23 | 15:00 ET | [8-K](/filings/0001104659-26-047445.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-26-047445 |
| 2026-03-27 | 13:31 ET | [DEF 14A](/filings/0001104659-26-035765.md) | Proxy statement, period 2026-05-06 | 0001104659-26-035765 |
| 2026-02-27 | 21:30 ET | [10-K](/filings/0001104659-26-021621.md) | Annual report, period 2025-12-31 | 0001104659-26-021621 |
| 2026-02-12 | 16:00 ET | [8-K](/filings/0001104659-26-014044.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-26-014044 |

## Latest annual report

[Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0001104659-26-021621.md), filed Feb 27, 2026.

## Forecast league

Not in this season’s league. [This season’s league](/leagues.md)

## About the filer

- CIK: 98677
- Tickers: TR, TROLB
- Exchange: NYSE
- SIC code: 2060 Sugar & Confectionery Products
- State of incorporation: VA
- Filer category: Large accelerated filer

Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 24, 2026, 15:21 ET. No prices; not investment advice.